Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Prevalence of the metabolic syndrome among Turkish adults

Abstract

Objective:

To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines.

Design:

The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9±14.9 years (range 20–90).

Results:

The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20–29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20–29 years to 74.6% in those aged 60–69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.

Conclusions:

The prevalence of the MS in the adult Turkish population is very high, especially in women. Our findings have important implications for public health in Turkey.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Abate N (2000). Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabet Complicat 14, 154–174.

    Article  CAS  Google Scholar 

  • Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003). Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diab Res Clin Pract 61, 29–37.

    Article  Google Scholar 

  • Chuang SY, Chen CH, Chou P (2004). Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 67, 611–620.

    PubMed  Google Scholar 

  • Das UND (2002). Metabolic syndrome X is common in South Asians, but why and how? Nutrition 18, 774–776.

    Article  Google Scholar 

  • Duc Son LNT, Kunii D, Hung NT, Sakai T, Yamamoto S (2005). The metabolic syndrome: prevalence and risk factors in the urban population of Ho Chi Minh City. Diabet Res Clin Pract 67, 243–250.

    Article  Google Scholar 

  • Enkhmaaa B, Shiwakua K, Anuurada E, Nogib A, Kitajimaa K, Yamasakia M et al. (2005). Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chim Acta 352, 105–113.

    Article  Google Scholar 

  • Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497.

  • Ford ES, Giles WH, Dietz WH (2002). Prevalence of metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 287, 356–359.

    Article  Google Scholar 

  • Grundy SM (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 83, 25F–29F.

    Article  CAS  Google Scholar 

  • Grundy SM, Abate N, Chandalia M (2002). Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med 113, 25S–29S.

    Article  CAS  Google Scholar 

  • Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K (2004). Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97, 257–261.

    Article  Google Scholar 

  • Hatemi H, Yumuk VD, Turan N, Arık N (2003). Prevalence of overweight and obesity in Turkey. Metab Syndr Relat Disord 1, 285–290.

    Article  Google Scholar 

  • Ilerigelen B, Kabakci G, Koylan N, Kozan O, Buyukozturk K (2005). Coexisting dyslipidemia in hypertensive patients (Abstract). Atherosclerosis 6 (Suppl), 156.

    Article  Google Scholar 

  • Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabet Care 24, 683–689.

    Article  CAS  Google Scholar 

  • Jacobson TA, Case CC, Roberts S, Buckley A, Murtaugh KM, Sung JCY et al. (2004). Characteristics of US adults with the metabolic syndrome and therapeutic implications. Diabet Obes Metab 6, 353–362.

    Article  CAS  Google Scholar 

  • Jensen T, Truong Q, Frandsen M, Dinesen B, Stender S (2002). Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients. Diabet Care 25, 1914–1918.

    Article  CAS  Google Scholar 

  • Kim ES, Han SM, Kim YI, Song KH, Kim MS, Kim WB et al. (2004). Prevalence and clinical characteristics of metabolic syndrome in a rural population of South Korea. Diabet Med 21, 1141–1143.

    Article  CAS  Google Scholar 

  • Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ (2004). Prevalence of the metabolic syndrome among 40 698 Korean metropolitan subjects. Diabet Res Clin Pract 65, 143–149.

    Article  Google Scholar 

  • Mahley RWW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V et al. (1995). Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36, 839–859.

    CAS  PubMed  Google Scholar 

  • Onat A, Sansoy V (2002). Metabolic syndrome, major culprit of coronary disease among turks: its prevalence and impact on coronary risk. Arch Turk Soc Cardiol 30, 8–15.

    Google Scholar 

  • Onat A, Yildirim B, Cetinkaya A, Aksu H, Keles I, Uslu N et al. (1999a). Indices of obesity and central obesity in Turkish Adults: distinct rise in obesity in 1990–98 more pronounced among men. Arch Turk Soc Cardiol 27, 209–217.

    Google Scholar 

  • Onat A, Yıldırım AB, Uslu N, Gürbüz N, Keles I, Çetinkaya A et al. (1999b). Plasma lipoproteins and apolipoproteins in Turkish adults: overall levels, associations with other risk parameters and HDL's role as a marker of coronary risk in women. Arch Turk Soc Cardiol 27, 72–79.

    Google Scholar 

  • Ozsahin AK, Gokcel A, Sezgin N, Akbaba M, Guvener N, Ozisik L et al. (2004). Prevalence of the metabolic syndrome in a Turkish adult population. Diabet Nutr Metab 17, 230–234.

    CAS  Google Scholar 

  • Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V et al. (2003). Metabolic syndrome in urban Asian Indian adults – a population study using modified ATP III criteria. Diabet Res Clin Pract 60, 199–204.

    Article  CAS  Google Scholar 

  • Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M (2006). Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 6, 92.

    Article  Google Scholar 

  • Satman I, Yilmaz MT, Sengul A, Salman S, Salman F, Uygur S et al. (2002). Population based study of diabetes and risk characteristics in Turkey. Results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabet Care 25, 1551–1556.

    Article  Google Scholar 

  • Thomas GN, Ho SY, Janus ED, Lam KSL, Hedley AJ, Lam TH (2005). The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabet Res Clin Practice 67, 251–257.

    Article  Google Scholar 

  • Thomas GN, Tomlinson B, Chan JCN, Lee ZSK, Cockram CS, Critchley JAJH (2000). An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. Am J Hypertens 13, 745–752.

    Article  CAS  Google Scholar 

  • Uzunlulu M, Oguz A, Tigen K (2005). High-density lipoprotein cholesterol in coronary artery disease patients: is it as low as expected? Anadolu Kardiyol Derg 5, 268–270.

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by an unrestricted grant from the Abdi İbrahim Pharmaceuticals.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Abaci.

Additional information

Guarantor: A Abaci.

Contributors: OK, AO, AA, CE, ZO, AT and SC participated in the design and conduct of the study. All the authors contributed to the writing and revision of the paper for which AA is guarantor. The order of the contributors was agreed among the investigators, and the first listed contributor made the greatest contribution to the paper, and then in decreasing order.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kozan, O., Oguz, A., Abaci, A. et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 61, 548–553 (2007). https://doi.org/10.1038/sj.ejcn.1602554

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602554

Keywords

This article is cited by

Search

Quick links